Evidence map›Paper›PMID 31615783›Full record

ArticleBMJ (Clinical research ed.)2019

EMA and FDA decisions based on flawed evidence to approve new cancer drugs negatively affect Latin American patients.

Carlos E Durán, Martín Cañás, Thierry Chistiaens

Open access · bronzeAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in BMJ (Clinical research ed.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries.Revista panamericana de salud publica = Pan American journal of public health · 2021
    Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Carlos E DuránHeymans Institute for Pharmacology, Ghent University, 9000 Ghent, Belgium.
Martín CañásInstituto de Ciencias de la Salud, Universidad Nacional Arturo Jauretche, Argentina.
Thierry ChistiaensHeymans Institute for Pharmacology, Ghent University, 9000 Ghent, Belgium.
Ghent University · BEUniversidad Nacional Arturo Jauretche · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsNeoplasmsDrug ApprovalHumansLatin AmericaUnited StatesUnited States Food and Drug AdministrationAntineoplastic Agents

Identifiers

PMID31615783
OpenAlexW2980533504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.